﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Genrated: Thu, 16 Apr 2026 04:38:56 GMT--><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:ev="http://purl.org/rss/1.0/modules/event/"><channel><title>American Pharmacists Association</title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/May-2020/rss/2083</link><atom:link href="http://www.pharmacist.com/Publications/Pharmacy-Today/May-2020/rss/2083" rel="self" type="application/rss+xml" /><description>RSS document</description><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[New and Approved]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/new-and-approved-30</link><description><![CDATA[  New drugs  

 COAGULATION FACTOR VIIA (RECOMBINANT)-JNCW 
(Sevenfact—Laboratoire Francais du Fractionnement et des Biotechnologies S.A.) 

  Drug class:  Recombinant analog of human FVII 

  ...]]></description><pubDate>Tue, 07 Apr 2020 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/new-and-approved-30</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2690]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Community pharmacists expand point-of-care testing]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/community-pharmacists-expand-point-of-care-testing</link><description><![CDATA[  Maria G. Tanzi, PharmD  

   

 Point-of-care testing (POCT) in pharmacies has grown from A1C and cholesterol screenings to testing for infectious diseases such as hepatitis C virus. POCT by ...]]></description><pubDate>Tue, 07 Apr 2020 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/community-pharmacists-expand-point-of-care-testing</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2684]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Reevaluating chlorthalidone as thiazide ‘diuretic of choice’]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/reevaluating-chlorthalidone-as-thiazide-diuretic-of-choice</link><description><![CDATA[  Maria G. Tanzi, PharmD  

   

 The 2017 American College of Cardiology/American Heart Association guidelines on management of hypertension currently recommend use of thiazide diuretics as ...]]></description><pubDate>Tue, 07 Apr 2020 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/reevaluating-chlorthalidone-as-thiazide-diuretic-of-choice</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2685]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[As one drug leaves the weight-loss market, many options remain]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/as-one-drug-leaves-the-weight-loss-market-many-options-remain</link><description><![CDATA[  Sonya Collins  

   

 In February, Eisai removed the weight-loss drug lorcaserin (Belviq, BelviqXR) from the market at FDA’s request. The request cited a safety clinical trial that found an ...]]></description><pubDate>Tue, 07 Apr 2020 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/as-one-drug-leaves-the-weight-loss-market-many-options-remain</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2686]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[First oral nonstatin drugs approved for high cholesterol in nearly 20 years]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/first-oral-nonstatin-drugs-approved-for-high-cholesterol-in-nearly-20-years</link><description><![CDATA[  Cara Aldridge Young  

 FDA recently approved bempedoic acid (Nexletol), the first once-daily, oral nonstatin drug to lower LDL-C in nearly 20 years, as well as bempedoic acid and ezetimibe ...]]></description><pubDate>Tue, 07 Apr 2020 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/first-oral-nonstatin-drugs-approved-for-high-cholesterol-in-nearly-20-years</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2687]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[NSAIDs for COVID-19]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/nsaids-for-covid-19</link><description><![CDATA[  Mary Warner  

   

 After a research article published in  Lancet  on March 11 indicated that use of ibuprofen may worsen COVID-19 symptoms, and the subsequent media attention, patients are ...]]></description><pubDate>Tue, 07 Apr 2020 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/nsaids-for-covid-19</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2688]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Self-care and COVID-19]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/self-care-and-covid-19</link><description><![CDATA[  Daniel L. Krinsky, RPh, MS  

   

 The COVID-19 crisis is affecting our lives in more ways than we could possibly imagine. As accessible health care providers on the front lines, pharmacists ...]]></description><pubDate>Tue, 07 Apr 2020 16:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/self-care-and-covid-19</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2689]]></dc:identifier></item></channel></rss>